(Bloomberg) -- Private equity firm GTCR raised $3.6 billion for a second strategic growth fund, surpassing its $2.75 billion target and boosting its firepower for smaller buyouts, according to a ...
CHICAGO, Feb. 20, 2025 /PRNewswire/ -- GTCR, a leading private equity firm, announced the final close of Strategic Growth Fund II ("SGF II" or the "Fund") with approximately $3.6 billion in ...
GTCR announced its acquisition of Surmodics for $627 million GTCR invested in Biocoat, a specialty manufacturer of hydrophilic biomaterial coatings, services and dip-coating equipment for medical ...
March 6 (Reuters) - The U.S. Federal Trade Commission sued on Thursday to block medical device coatings maker Surmodics' (SRDX.O), opens new tab acquisition by private equity firm GTCR ...
Gifting allows recipients to access the article for free. The U.S. Federal Trade Commission has moved to block private-equity firm GTCR’s acquisition of Surmodics Inc., saying the deal would ...